There’s an ongoing push to improve health care affordability and reduce out-of-pocket costs, especially for prescription ...

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...

Adjusted EBITDA margin increased to 37.2% from 25.2% in Q4 2024, driven by cost reductions and operational improvements. Management's tone shifted positively, highlighting stronger-than-expected ...

“Insulin used to cost around $500 for one box, and now it’s down to somewhere around $150, $200, so they’ve really dropped ...

Novo Nordisk today announced 2024 earnings, reporting a 26% increase in annual sales to ~$40.56bn. Read why I upgrade NVO ...

Patients at these clinics pay a fee of roughly $50 to $100 month and get easier, direct access to their doctor for routine ...

As insulin prices in the United States continue to rise, making it increasingly difficult for diabetic patients to afford ...

If California patients pay more than $35 per month for insulin now, it’s in large part because PBMs have rigged the system in ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...

Donald Trump is executing a shock-and-awe strategy, burying the public in a smoky cloud of flamboyant proposals. Some, like ...